Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

A US-based pharmaceutical company known for its revolutionary mRNA technology, has completed construction of its Moderna Innovation and Technology Centre (MITC) at Harwell in Oxfordshire.

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

On March 11 th 2020, the World Health Organization (WHO) declared that COVID-19 was a global pandemic. In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech ...

The measure would seem a premptive strike at a growing industry. No food engineered to include vaccines are approved for use ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...